Pediatrics

GSK Lullaby-002
Investigational Varicella Vaccine
Your child may be eligible if they:
-
are between the ages of 12 and 15 months
-
have no history of varicella (chicken pox) infection
-
do not have a history of any reaction or hypersensitivity likely to be exacerbated by any component of the study interventions

Scan this QR code to access a video.
Visit www.lullabychickenpoxprogram.com to learn more.
Rheumatology

Eli Lilly Psoriatic Arthritis with Obesity
Ixekizumab together with tirzepatide
You may qualify if you:
-
at least 18 years of age
-
have a diagnosis of psoriatic arthritis
-
have a BMI of 30 kg/m2 or greater (obesity) or
27 kg/m2 to <30 kg/m2 (overweight) in the
presence of at least 1 weight-related comorbid condition (hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease) -
have been treated with ixekizumab for approximately 3 months (±1 month) prior to adding tirzepatide
Dermatology
Novartis Hidradenitis Suppurativa
Investigational BTK Inhibitor tablet/placebo
You may qualify if you:
-
are at least 18 years of age
-
have at least 5 inflammatory lesions, abscesses, or fistulas in 2 distinct locations (i.e. armpit, groin, breast)
-
are not currently taking medication for your HS
.jpeg)
Otolaryngology

Sanofi Chronic Rhinosinusitis with Nasal Polyps
Subcutaneous Lunsekimig/placebo
-
Are you between the ages of 18 and 70?
-
Are you experiencing chronic pain or pressure in your sinuses?
-
Are you congested all the time, even when it's not allergy season?
-
Must have a confirmed diagnosis of nasal polyps
Don't see a study for you?
Your voice matters! Fill out the form below to be contacted for research studies you may qualify for!